Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TERGS0001 myoblast sheet transplantation after ESD for superficial nonampullary duodenal epithelial tumor
jRCT2073210094Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Apr 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of TERGS0001 in superficial nonampullary duodenal epithelial tumor (SNADET), sponsored by Japan Agency for Medical Research and Development. Primary endpoints: Onset of peritonitis after delayed perforation within postoperative 3 days, All adverse events during the follow-up period and 2 more. Started Apr 2021; status: recruiting.
02
Drugs
TERGS0001
03
Conditions
superficial nonampullary duodenal epithelial tumor (SNADET)
Beyond the preview
Go deeper on jRCT2073210094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2073210094.